REFERENCES
- McQuay H. Opioids in pain management. Lancet. 1999:3523: 2229–2232.
- Heit HA. Addiction, physical dependence, and tolerance: precise definitions to help clinicians evaluate and treat chronic pain patients. J Pain Palliat Care Pharmacother. 2003;17(1):15–29.
- Inturrisi CE, Lipman AG. Opioids Analgesics. In Fishman SM, Ballantyne JC, Rathmell JP, editors, Bonica's Pain Management, 4th edition, Philadelphia, Wolters Kluwer/ Lippincott Williams and Wilkins, 2010.
- Papagallo M. The concept of pseudotolerance to opioids. J Pharm Care Pain Symptom Control. 1998;6(2):95–98.
- Daniell HW, Lentz R, Mazer NA. Open-label pilot study of testosterone patch therapy in men with opioid-induced androgen deficiency. J Pain. 2006;7(3):200–210.
- Daniell HW. Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain. J Pain. 2008;9(1):28–36.
- Chang G, Chen L, Mao J. Opioid tolerance and hyperalgesia. Med Clin North Am. 2007;91(2):199–211.
- Chapman, CR, Bradshaw DH. Only modest long-term opioid dose escalation occurs over time in chronic non-malignant pain management. J Pain Palliat Care Pharmacother. 2013;27, this issue.